In the wake of COVID-19 outbreak globally, government agencies in India and others (globally) have set out guidance for researchers. Following is a list of important links which may help researchers access relevant information and publications:
Please note the WHO has requested that the WHO official acronym for the Coronavirus disease (COVID-19) is to be entered in the title field of the trial registration dataset. This will facilitate finding and extracting all clinical trials related to COVID-19, from the public databases.
Guidance for research applications to support COVID-19 R&D in India
Central Drugs Standard Control Organization (CDSCO)
The document details on the timeline laid down by DBT in consultation with the Drug Controller General of India (DCGI), to fast track the regulatory approval process of applications for development of vaccines, diagnostics, prophylactics and therapeutics for COVID-19.
Important links from global agencies:
Guidance for managing existing clinical trials during COVID-19
Medicines and Healthcare products Regulatory Agency (MHRA) (UK Government)
Department of Biotechnology (DBT) and Biotechnology Industry Research Assistance Council (BIRAC)
DBT and BIRAC have announced a COVID-19 Research Consortium, and seek Request for Proposals, with a focus on diagnostics, vaccines, novel therapeutics, repurposing of drugs or any other intervention for control of COVID-19.
Technology Development Board (TDB), Department of Science and Technology (DST)